September 19, 2016
As Ohio’s overdose epidemic has climbed toward a record high, an army of lobbyists representing makers of prescription painkillers and their allies poured more than $3.5 million into Ohio political coffers. Pharmaceutical companies and allied groups belonging to the Pain …
September 6, 2016
Johnson & Johnson persuaded a New Jersey judge to throw out two women’s lawsuits blaming the health-care company’s talcum powder for their ovarian cancer. The ruling may help J&J fend off more than 1,000 suits in state and federal courts …
May 26, 2016
California has accused Johnson & Johnson of failing to warn doctors and patients about the severity and frequency of complications associated with its pelvic mesh devices. According to the lawsuit filed by the state’s attorney general on Tuesday, J&J and …
May 4, 2016
Johnson & Johnson must pay $55 million to a 62-year-old South Dakota woman who blamed her ovarian cancer on the company’s talcum powder in the second such trial loss this year. J&J is accused in more than 1,000 lawsuits in …
March 18, 2016
Johnson & Johnson was ordered to pay $502 million to a group of patients who accused the company of hiding flaws in its Pinnacle artificial hips that caused the devices to prematurely fail and left them facing surgeries and pain, …
February 23, 2016
Johnson & Johnson must pay $72 million to the family of a woman who blamed her fatal ovarian cancer on the company’s talcum powder in the first state-court case over the claims to go to trial. Jurors in St. Louis …
October 19, 2015
Johnson & Johnson defeated a lawsuit claiming it had improperly designed its Tylenol pain reliever in the first case to go to trial over the link between the widely used over-the-counter drug and liver damage, according to a J&J spokesman. …
August 13, 2015
Managing general agency Johnson & Johnson, Inc. (J&J) has acquired John Handel & Associates, Inc. (JHA), located in St. Petersburg, Fla. Under its new ownership, JHA will continue to offer the same products and services throughout the state of Florida, …
July 13, 2015
South Carolina’s highest court further reduced the penalty against a Johnson & Johnson subsidiary accused of deceptive marketing of an anti-psychotic drug. The decision was to substitute the same verdict the court reached in February in order to correct a …
February 27, 2015
South Carolina’s Supreme Court ordered Johnson & Johnson to pay a penalty of $136 million, upholding a jury’s finding that the drugmaker’s Janssen unit had improperly marketed its anti-psychotic drug Risperdal and concealed its risks. A trial court had earlier …